Starting Colorectal Cancer Screening at Age 40 Cuts Death Risk by 39%, Study Finds
Structured Exercise Program Improves Outcomes, Quality of Life in Colon Cancer
FIT Outperforms Blood-Based cfDNA Test in Detecting Precancerous Colorectal Lesions
Exploring Amivantamab's Potential in Colorectal Cancer: Dirk Arnold, MD, PhD
The Importance of Early Screening, Biomarker Testing, and Support in Colorectal Cancer Care
Tackling Colorectal Cancer Care Inequities Through Patient Advocacy Groups
Patients With Colorectal Cancer Seek More Say in Treatment, Face Financial Barriers
A Look at Cancers Where Biomarkers Are Needed
Dr Ajay Goel Explains Effectiveness of Liquid Biopsies, Tissue-Based Biomarkers in Treating CRC
Dr Ajay Goel Discusses New Methods of Testing for EOCRC, Recurrence
Botensilimab and Balstilimab in Refractory Microsatellite Stable (MSS) mCRC
Impact of Microsatellite Stability in Metastatic Colorectal Cancer
Utilizing RWE to Address Unmet Needs for CRC